Altogether, these data suggest that loss of differentiation and acquisition of resistance to MAPK/ERK pathway inhibition is delineated by a reduction in the dependency on this pathway, with a concurrent increase in PI3K/AKT signaling that confers melanoma cells with stem-like properties. Here, AKT1 is linked to melanoma.